These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 31296995)
1. Early or deferred treatment of smoldering multiple myeloma: a meta-analysis on randomized controlled studies. Zhao AL; Shen KN; Wang JN; Huo LQ; Li J; Cao XX Cancer Manag Res; 2019; 11():5599-5611. PubMed ID: 31296995 [TBL] [Abstract][Full Text] [Related]
2. Early versus deferred treatment for smoldering multiple myeloma: a meta-analysis of randomized, controlled trials. Gao M; Yang G; Tompkins VS; Gao L; Wu X; Tao Y; Hu X; Hou J; Han Y; Xu H; Zhan F; Shi J PLoS One; 2014; 9(10):e109758. PubMed ID: 25279718 [TBL] [Abstract][Full Text] [Related]
3. The effect of intervention versus watchful waiting on disease progression and overall survival in smoldering multiple myeloma: a systematic review of randomized controlled trials. Ojo AS; Ojukwu SG; Asemota J; Akinyemi O; Araoye MO; Saleh M; Ali A; Sarma R J Cancer Res Clin Oncol; 2022 Apr; 148(4):897-911. PubMed ID: 35059867 [TBL] [Abstract][Full Text] [Related]
4. Immediate versus deferred percutaneous coronary intervention for patients with acute coronary syndrome: A meta-analysis of randomized controlled trials. Li W; He W; Zhou Y; Guo Y PLoS One; 2020; 15(7):e0234655. PubMed ID: 32614851 [TBL] [Abstract][Full Text] [Related]
5. Evaluating early intervention in smoldering myeloma clinical trials: a systematic review. Kakkilaya A; Trando A; Cliff ERS; Mian H; Al Hadidi S; Aziz M; Goodman AM; Jeong AR; Smith WL; Kelkar AH; Russler-Germain DA; Mehra N; Chakraborty R; Gertz MA; Mohyuddin GR Oncologist; 2024 Sep; ():. PubMed ID: 39236068 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic Advances in the Management of Smoldering Myeloma. Khan R; Zahid U; Kollu V; Jahan N; Ali M; Tricot G; Anwer F Am J Ther; 2020; 27(2):e194-e203. PubMed ID: 31842112 [TBL] [Abstract][Full Text] [Related]
7. Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma. Korde N; Roschewski M; Zingone A; Kwok M; Manasanch EE; Bhutani M; Tageja N; Kazandjian D; Mailankody S; Wu P; Morrison C; Costello R; Zhang Y; Burton D; Mulquin M; Zuchlinski D; Lamping L; Carpenter A; Wall Y; Carter G; Cunningham SC; Gounden V; Sissung TM; Peer C; Maric I; Calvo KR; Braylan R; Yuan C; Stetler-Stevenson M; Arthur DC; Kong KA; Weng L; Faham M; Lindenberg L; Kurdziel K; Choyke P; Steinberg SM; Figg W; Landgren O JAMA Oncol; 2015 Sep; 1(6):746-54. PubMed ID: 26181891 [TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates in multiple myeloma: a network meta-analysis. Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B Cochrane Database Syst Rev; 2012 May; (5):CD003188. PubMed ID: 22592688 [TBL] [Abstract][Full Text] [Related]
9. Progress in the Management of Smoldering Multiple Myeloma. Schmidt TM; Callander NS Curr Hematol Malig Rep; 2021 Apr; 16(2):172-182. PubMed ID: 33983517 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of smoldering multiple myeloma based on nationwide screening. Thorsteinsdóttir S; Gíslason GK; Aspelund T; Rögnvaldsson S; Óskarsson JÞ; Sigurðardóttir GÁ; Þórðardóttir ÁR; Viðarsson B; Önundarson PT; Agnarsson BA; Sigurðardóttir M; Þorsteinsdóttir I; Ólafsson Í; Eyþórsson E; Jónsson Á; Berlanga O; Hultcrantz M; Durie BGM; Löve TJ; Harding S; Landgren O; Kristinsson SY Nat Med; 2023 Feb; 29(2):467-472. PubMed ID: 36747117 [TBL] [Abstract][Full Text] [Related]
12. Smoldering Multiple Myeloma: To Treat or Not to Treat. Kapoor P; Rajkumar SV Cancer J; 2019; 25(1):65-71. PubMed ID: 30694862 [TBL] [Abstract][Full Text] [Related]
13. Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure. Leone MA; Giussani G; Nolan SJ; Marson AG; Beghi E Cochrane Database Syst Rev; 2016 May; 2016(5):CD007144. PubMed ID: 27150433 [TBL] [Abstract][Full Text] [Related]
14. New approaches to smoldering myeloma. Mateos MV; San Miguel JF Curr Hematol Malig Rep; 2013 Dec; 8(4):270-6. PubMed ID: 23975678 [TBL] [Abstract][Full Text] [Related]
15. Advances in the management of asymptomatic myeloma. Mateos MV Curr Opin Oncol; 2014 Nov; 26(6):670-6. PubMed ID: 25210868 [TBL] [Abstract][Full Text] [Related]
16. The Role of Early Intervention in High-Risk Smoldering Myeloma. Joseph NS; Dhodapkar MV; Lonial S Am Soc Clin Oncol Educ Book; 2020 Mar; 40():1-9. PubMed ID: 32182141 [TBL] [Abstract][Full Text] [Related]